Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation-Reference-Cited by-同舟云学术

Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation

Published:2022-02 Issue:2 Volume:17 Page:214-227
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Rolfo Christian,Meshulami Noy,Russo Alessandro,Krammer Florian,García-Sastre Adolfo,Mack Philip C.,Gomez Jorge E.,Bhardwaj Nina,Benyounes Amin,Sirera Rafael,Moore Amy,Rohs Nicholas,Henschke Claudia I.,Yankelevitz David,King Jennifer,Shyr Yu,Bunn Paul A.,Minna John D.,Hirsch Fred R.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference75 articles.

1. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study;Maringe;Lancet Oncol,2020

2. Incidence of SARS-CoV-2 infection among patients undergoing active antitumor treatment in Italy;Aschele;JAMA Oncol,2021

3. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection;Wang;JAMA Oncol,2021

4. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: a systematic review and meta-analysis;Tagliamento;Crit Rev Oncol Hematol,2021

5. Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer;Barrière;Eur J Cancer,2021

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19;Frontiers in Immunology;2024-09-06

2. Gefitinib Resensitization After a TKI-Free Interval in Osimertinib Resistant Non-Small-Cell Lung Cancer: A Glimpse of Hope in Time of Crisis?;CLIN LUNG CANCER;2024

3. Gefitinib Resensitization After a TKI-Free Interval in Osimertinib Resistant Non–Small-Cell Lung Cancer: A Glimpse of Hope in Time of Crisis?;Clinical Lung Cancer;2024-09

4. Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis;Clinical Lung Cancer;2024-07

5. Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer;Vaccines;2024-06-26